The manufactures of popular Low-T product, Testim, have agreed to settle all pending cases against them. Auxilium Pharmaceuticals, Endo Pharmaceuticals and GlaxoSmithKline have reached an agreement to settle about 1,300 cases brought on behalf of males who have suffered injuries after using testosterone replacement therapy. These cases are part of the Multidistrict Litigation (MDL) court in Chicago that involves more than 6,000 cases brought against various drug makers for failing to warn doctors and patients about the potential side effects of testosterone replacement treatments. Testosterone Replacement Therapy has been associated with an increased risk of heart attack, stroke, blood clots, pulmonary embolism, and deep vein thrombosis (DVT).
Because of the settlement, the court has ruled that all proceedings involving cases against Endo, Auxilium and GSK will be stayed for 45 days, so that the parties can finalize the Master Settlement Agreement. As a result, pending trial dates scheduled were vacated. The agreement to resolve all Testim lawsuits comes shortly after a recent Axiron settlement reached by Eli Lilly to resolve all cases involving their competing testosterone product. That said, the terms of neither deal have been disclosed yet. While both of these global testosterone settlements are expected to resolve thousands of lawsuits, no agreements have been made for Androgel or Androderm lawsuits.
If you believe that you suffered adverse health effects as a result of taking prescription testosterone, you may be eligible for compensation for your pain and suffering. To have Forester Haynie start working on your case immediately, simply complete the online process below or call 1-844-999-DRUG to speak with an experienced attorney in complete confidence. You pay nothing until your case is settled!SIGN UP NOW